TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 115 filers reported holding TRICIDA INC in Q4 2020. The put-call ratio across all filers is 2.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,862,000 | -77.2% | 192,353 | -83.4% | 0.00% | -100.0% |
Q4 2020 | $8,168,000 | -29.7% | 1,158,637 | -9.7% | 0.00% | 0.0% |
Q3 2020 | $11,624,000 | -88.6% | 1,283,011 | -65.4% | 0.00% | -92.3% |
Q2 2020 | $101,818,000 | +32.6% | 3,705,162 | +6.2% | 0.01% | +8.3% |
Q1 2020 | $76,786,000 | -54.1% | 3,490,263 | -21.2% | 0.01% | -45.5% |
Q4 2019 | $167,159,000 | +31.1% | 4,429,218 | +7.2% | 0.02% | +22.2% |
Q3 2019 | $127,516,000 | -17.2% | 4,130,746 | +5.9% | 0.02% | -18.2% |
Q2 2019 | $153,946,000 | +73.5% | 3,901,325 | +69.8% | 0.02% | +69.2% |
Q1 2019 | $88,752,000 | +236.7% | 2,298,094 | +105.6% | 0.01% | +225.0% |
Q4 2018 | $26,359,000 | -13.9% | 1,117,839 | +11.6% | 0.00% | 0.0% |
Q3 2018 | $30,604,000 | +2.1% | 1,001,781 | -0.1% | 0.00% | -20.0% |
Q2 2018 | $29,987,000 | – | 1,002,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |